Relationship between changes in bone mineral density and fracture risk reduction with antiresorptive drugs: some issues with meta-analyses. by Delmas, P, Li, Z, Cooper, C

Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation. by Delmas, P, Rizzoli, R, Cooper, C, Reginster, J

Genetic influence on bone turnover in postmenopausal twins. by Garnero, P, Arden, N, Griffiths, G, Delmas, P, Spector, T

Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease. by Kanis, J, Delmas, P, Burckhardt, P, Cooper, C, Torgerson, D

Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system by Bruyère, O, Burlet, N, Delmas, P, Rizzoli, R, Cooper, C, Reginster, J

Matrix delivery transdermal 17beta-estradiol for the prevention of bone loss in postmenopausal women. The International Study Group. by Cooper, C, Stakkestad, J, Radowicki, S, Hardy, P, Pilate, C, Dain, M, Delmas, P

A number of osteocalcin antisera recognize epitopes on proteins other than osteocalcin in cultured skin fibroblasts: implications for the identification of cells of the osteoblasti... by Bradbeer, J, Virdi, A, Serre, C, Beresford, J, Delmas, P, Reeve, J, Triffitt, J

European guidance for the diagnosis and management of osteoporosis in postmenopausal women (Osteoporosis International DOI: 10.1007/s00198-008-0560-z) by Kanis, J, Burlet, N, Cooper, C, Delmas, P, Reginster, J, Borgstrom, F, Rizzoli, R

European guidance for the diagnosis and management of osteoporosis in postmenopausal women. by Kanis, J, Burlet, N, Cooper, C, Delmas, P, Reginster, J, Borgstrom, F, Rizzoli, R

European guidance for the diagnosis and management of osteoporosis in postmenopausal women (vol 19, pg 399, 2008) by Kanis, J, Burlet, N, Cooper, C, Delmas, P, Reginster, J, Borgstrom, F, Rizzoli, R, European, S

Matrix delivery transdermal 17 beta-estradiol for the prevention of bone loss in postmenopausal women by Cooper, C, Stakkestad, J, Radowicki, S, Hardy, P, Pilate, C, Dain, M, Delmas, P, Grp, I

Urinary CTX-II and glucosyl-galactosyl-pyridinoline are associated with both presence and severity of radiographic knee osteoarthritis by Jordan, K, Syddall, H, Sayer, A, Dennison, E, Gamero, P, Delmas, P, Cooper, C, Arden, N

Radiographic knee osteoarthritis presence and severity is associated with the urinary biochemical markers CTX-II and glucosyl-galactosyl-pyridinoline by Jordan, K, Syddall, H, Sayer, A, Dennison, E, Garnero, P, Delmas, P, Cooper, C, Arden, N

Urinary CTX-II and glucosyl-galactosyl-pyridinoline are associated with the presence and severity of radiographic knee osteoarthritis in men. by Jordan, K, Syddall, H, Garnero, P, Gineyts, E, Dennison, E, Sayer, A, Delmas, P, Cooper, C, Arden, N

Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data. by Cranney, A, Wells, G, Yetisir, E, Adami, S, Cooper, C, Delmas, P, Miller, P, Papapoulos, S, Reginster, J, Sambrook, P, Silverman, S, Siris, E, Adachi, J

A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate. by Reginster, J, Felsenberg, D, Cooper, C, Stakkestad, J, Miller, P, Kendler, D, Adami, S, McClung, MR, Bolognese, M, Civitelli, R, Dumont, E, Bonvoisin, B, Recker, R, Delmas, P

Prior clinical vertebral fractures are a particularly strong predictor of hip fracture: A meta-analysis by Johnell, O, Kanis, J, Johansson, H, Oden, A, Delmas, P, Eisman, J, Fujiwara, S, Kroger, H, McCloskey, E, Melton, L, Pols, H, Reeve, J, Silman, A, Tenenhouse, A

Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study. by Reginster, J, Adami, S, Lakatos, P, Greenwald, M, Stepan, J, Silverman, S, Christiansen, C, Rowell, L, Mairon, N, Bonvoisin, B, Drezner, M, Emkey, R, Felsenberg, D, Cooper, C, Delmas, P, Miller, P

A comparison of bone mineral measurements for fracture prediction: A meta-analysis by Johnell, O, Kanis, J, Johansson, A, Oden, A, Delmas, P, Eisman, J, Fujiwara, S, Gluer, C, Kroger, H, McCloskey, E, Mellstrom, D, Melton, L, Pols, H, Reeve, J, Silman, A, Tenenhouse, A

Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study. by Miller, P, McClung, MR, Macovei, L, Stakkestad, J, Luckey, M, Bonvoisin, B, Reginster, J, Recker, R, Hughes, C, Lewiecki, E, Felsenberg, D, Delmas, P, Kendler, D, Bolognese, M, Mairon, N, Cooper, C